SEC Form 4 · accession 0000899243-18-027218
LogicBio Therapeutics, Inc. · LOGC
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
A later amendment supersedes this filing — read the amendment. The figures below are kept as originally reported (version chain, not an overwrite).
Reporting owner
Dean Falb
Officer — Chief Scientific Officer
Period of report
Oct 18, 2018
Accepted (ET)
Oct 22, 2018 · 9:16 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001664106
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Employee Stock Option (right to buy)F1 | $10.00 | Oct 18, 2018 | A | 41,134 | A | — | Oct 17, 2028 | Common Stock | 41,134 | 41,134 | D |
Explanation of responses
- F1The option becomes exercisable in equal one forty-eighth installments from the vesting commencement date, October 18, 2018.